High-efficiency homology-directed insertion into the genome using the engineered homing endonuclease ARCUS
Nucleic Acids Research · 23.09.2025 · 53 (18)
DOI: 10.1093/nar/gkaf961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 06.10.2025. Verfasst von Laura Christian Resly und 13 weiteren Autor:innen. Beteiligte Einrichtung: Precision BioSciences, Inc. Durham, NC, United States. Hauptthemen laut MEDLINE: Genome, Human, Homologous Recombination, Endonucleases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Precision BioSciences.
Abstract (Originalsprache)
Several gene editing tools have entered the clinic, representing varied options for eliminating or correcting mutations. Although gene editing by homologous recombination (HR) can potentially accomplish any type of gene edit (insertions, deletions, and replacements), as the outcome is defined by a recombinant repair template, gene editing enzymes that support efficient HR are rare. ARCUS nucleases, engineered from the homing endonuclease I-CreI, have programmable sequence specificity and support precise, high-frequency transgene insertion. In this study, we demonstrate that the 3′ overhangs that ARCUS nucleases generate when cutting DNA are key to triggering high rates of HR. We show that a single editor can be used to accomplish the full range of currently understood DNA editing approaches, allowing all combinations of single base changes, introducing small, specific deletions, small and large insertions, and the ability to replace large segments of genomic DNA with efficiencies ranging from 60% to 90% in lymphocytes. ARCUS also supports precise, efficient insertion (30%–40%) in noncycling hepatocytes via nonclassical HR pathways. Collectively, this work characterizes a flexible and efficient gene insertion system for potential therapeutic use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Precision BioSciences, Inc. Durham, NC, United States.
ORCID-Profile: Aaron J Martin
Förderung
- Precision BioSciences
Zitieren
APA
Resly, L. C., Tubbs, A. L., Vogel, A. J., Hux, J. A., MacDonald, I. A., Harris, J., Mischler, A., Tomberlin, G. H., Evans, K. S., Thompson, R., Sunman, J., Lape, J., Smith, J. J., & Martin, A. J. (2025). High-efficiency homology-directed insertion into the genome using the engineered homing endonuclease ARCUS. Nucleic Acids Research, 53(18). https://doi.org/10.1093/nar/gkaf961
Vancouver
Resly LC, Tubbs AL, Vogel AJ, Hux JA, MacDonald IA, Harris J, et al. High-efficiency homology-directed insertion into the genome using the engineered homing endonuclease ARCUS. Nucleic Acids Research. 2025;53(18). doi:10.1093/nar/gkaf961
BibTeX
@article{Resly2025,
author = {Resly, Laura Christian and Tubbs, Alan L and Vogel, Alexander J and Hux, Jo Ann and MacDonald, Ian A and Harris, Jason and Mischler, Adam and Tomberlin, Ginger H and Evans, Kathryn S and Thompson, Rhese and Sunman, Jeffrey and Lape, Janel and Smith, J Jeff and Martin, Aaron J},
title = {High-efficiency homology-directed insertion into the genome using the engineered homing endonuclease ARCUS},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {18},
doi = {10.1093/nar/gkaf961}
}
EUVIMED